69145-58-0Relevant academic research and scientific papers
Design and synthesis of novel sulfonamide-containing bradykinin hB 2 receptor antagonists. 1. Synthesis and SAR of α,α- dimethylglycine sulfonamides
Fattori, Daniela,Rossi, Cristina,Fincham, Christopher I.,Berettoni, Marco,Calvani, Federico,Catrambone, Fernando,Felicetti, Patrizia,Gensini, Martina,Terracciano, Rosa,Altamura, Maria,Bressan, Alessandro,Giuliani, Sandro,Maggi, Carlo A.,Meini, Stefania,Valenti, Claudio,Quartara, Laura
, p. 3602 - 3613 (2007/10/03)
We recently published the extensive in vivo pharmacological characterization of MEN 16132 (J. Pharmacol. Exp. Ther. 2005, 616-623; Eur. J. Pharmacol. 2005, 528, 7), a member of the sulfonamide-containing human B 2 receptor (hB2R) ant
NON-PEPTIDE BRADYKININ ANTAGONISTS AND PHARMACEUTICAL COMPOSITIONS THEREFROM
-
Page/Page column 9, (2010/11/08)
Non-peptide compounds having activity as selective antagonists of bradykinin (BK) B2 receptor. The compounds are chemically characterized by the presence of an amino acid alpha substituted with a cyclic group and by a tetraalkylammonium group.
Sulfonyl chloride as a disposable electron withdrawing substituent in halex fluorinations
Kageyama, Hiroyuki,Suzuki, Hiroshi,Kimura, Yoshikazu
, p. 85 - 89 (2007/10/03)
Syntheses of 1,3-difluorobenzene and 2,6-difluorotoluene are described via chlorosulfonation, catalytic Halex-fluorination, and desulfination of 1,3-dichlorobenzene and 2,6-dichlorotoluene.
